跳至主要内容
临床试验/NCT02842502
NCT02842502Unknown不适用

Clinical Feasibility of an Advanced Therapy Medicinal Product (ATMP) Preparation for Autologous Skin Regeneration in Patients Carriers of Leg Ulcers

Centre Hospitalier Universitaire de Besancon2 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
7
试验地点
2
主要终点
Number of skin substitute reconstructed with cells isolated from patient biopsies

研究概览

简要总结

This study deals with the feasibility of an ATMP (Advanced Therapy Medicinal Product) production for the treatment of chronic wounds ulcer. Recruitment concerns patients (n=7) with leg ulcers and receiving a skin pellet graft. During surgical procedure, supernumerary biopsies are planned to be done in order to be transferred to laboratory. Then, the possibility of cell extraction (keratinocytes and fibroblasts), expansion, banking and use for skin substitute production in clinical condition is evaluated (primary outcome).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with chronic leg ulcers evolving for more than 6 months
  • Patient to receive skin pellet transplant
  • Chronic wound area between 10 and 30 cm²

排除标准

  • Patient without health insurance,
  • Pregnant womens,
  • Smoking patient,
  • Chronic wound area >30 cm²

结局指标

主要结局

Number of skin substitute reconstructed with cells isolated from patient biopsies

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验